ReCode Therapeutics on Tuesday closed an extension round to its Series B financing, bringing in an additional $50 million for a total haul this funding round of $260 million.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,